Today’s breakthrough is tomorrow’s standard. Subcutaneous ICD is the first implantable cardiac device to protect patients against both sudden cardiac death and transvenous lead complications, and researchers are continuing to push this technology to the forefront of the electrophysiology field. Join host Wyatt Stahl as he reviews clinical evidence, contextualizes the data and speaks with principal investigators of landmark S-ICD trials — all to cut straight to the heart of this exciting technology. ABOUT THE HOST: Wyatt Stahl is an electrical engineer and a 30-year veteran in cardiac rhythm management, with over a decade of in-field experience alongside both implanters and physicians. Throughout his career, his work has largely focused on electrode-to-tissue long-term maturation and impedance changes with implantable devices.